Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • BOC Sciences: A Robust Isotope Labeling Service Vendor

    May 27, 2022, 09:12 AM by
    BOC Sciences offers professional stable isotope labeling services to support worldwide partners from preclinical to commercial stages.
    Full story
  • Complete Virtual Screening Solutions at BOC Sciences to Unleash Novel Drug Discovery Potential

    May 27, 2022, 09:12 AM by
    Today, BOC Sciences released a complete set of virtual screening solutions to help partners maximize the diversity of hits using its ultra-large-scale purchasable compound libraries.
    Full story
  • BOC Sciences Unveils Access to Comprehensive Set of PROTAC In Vitro Evaluation Services

    May 27, 2022, 09:12 AM by
    BOC Sciences today unveiled access to its comprehensive set of PROTAC in vitro evaluation services for biopharmaceutical clients and partners to expedite their PROTAC development from preclinical studies to clinical trials.
    Full story
  • Creative Peptides Unveils Product Portfolio of Standard Fmoc/Boc-PNA Monomers

    May 27, 2022, 09:12 AM by
    Creative Peptides supplies standard Fmoc- and Boc-PNA monomers that can be ordered in large quantities with high purity, solubility, and reactivity.
    Full story
  • Alfa Chemistry Catalysts Releases Asymmetric Organocatalysts for Chemical Reactions

    May 26, 2022, 09:30 AM by
    As a reliable source for versatile catalysts, Alfa Chemistry Catalysts today announces that it has launched a rich of collection of asymmetric organocatalysts, including chiral amines, chiral amino acids, chiral ammonium salts, chiral bicyclic guanidines, chiral diols, chiral imidazolidinones, chiral isothioureas, chiral n-heterocyclic carbenes (NHC), chiral oxazaborolidines, chiral sulfonic acids, cinchona alkaloids, and prolines, proline analogs. All can be used to accelerate different types of chemical reactions for research and production, whereas all are of high purity and of high-popularity among consumers.
    Full story
  • MicrobioSeq Releases Nanopore-Based Microbial Epigenomics Solutions to Accelerate Your Research

    May 26, 2022, 09:27 AM by
    Full story
  • CD Genomics Supercharges Transcriptomics Research by Digital RNA Sequencing Technology

    May 26, 2022, 09:27 AM by
    Full story
  • Cloud-Based HIV Registry, Oxford Nanopore Catalogs Structural Variants, More

    May 26, 2022, 01:00 AM by User Not Found
    Bio-IT World | Proscia launches an automated quality-control application that leverages artificial intelligence to improve drug development; an end-to-end software and data management package aids antibody discovery; ArisGlobal acquires BI’s analytic system; a data cloud is used for increased statistical analysis efficiency; new products from SCIEX and Dotmatics, and more.
    Full story
  • uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management

    May 25, 2022, 13:14 PM by
    uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management LONDON and NEW YORK, May 25, 2022-- uMotif today announced a new investment of $25.5m from a fund managed by Athyrium Capital Management, LP, the New York-based investment firm. The new funding will support continued scale up of uMotif's unique patient-first software platform for clinical research.
    Full story
  • CD BioSciences Introduces Comprehensive Solutions for GPCR Expression

    May 25, 2022, 09:10 AM by
    CD BioSciences introduces comprehensive solutions for GPCR expression based on various strategies and technique platforms to facilitate customers’ cutting-edge programs.
    Full story
  • STEMart Introduces Biocompatibility Evaluation of Breathing Gas Pathways in Medical Devices

    May 25, 2022, 09:10 AM by
    STEMart expands its Biocompatibility Testing services and introduces biocompatibility evaluation of breathing gas pathways in medical devices.
    Full story
  • Amerigo Scientific Supports Microbiology Research with the Launch of HHD BROTH

    May 25, 2022, 09:10 AM by
    Amerigo Scientific now introduces HHD Broth to the life science research community.
    Full story
  • Creative Diagnostics Launches Antibody-dependent Enhancement Assay Services

    May 25, 2022, 09:10 AM by
    Creative Diagnostics recently introduces comprehensive services for antibody-dependent enhancement (ADE) assay.
    Full story
  • Follow the Money: Data Protection and Security, Precision Medicine Platform, More

    May 25, 2022, 01:00 AM by User Not Found
    Bio-IT World| Funding for data protection and security platforms, autologous cell therapies, rapid DNA sequencing, and more.
    Full story
  • New Research Shows More Americans Avoiding Healthcare Due to Uncertainty About Costs

    May 24, 2022, 14:14 PM by
    HealthSparq Annual Consumer Survey Reveals Strong Support for Price Transparency Government Mandates
    Full story
  • Thermo Fisher Scientific and Qatar Genome Program Partner to Advance Precision Medicine

    May 24, 2022, 09:26 AM by
    Full story
  • MMS Holdings Selects THREAD as Partner of Choice to Deliver Decentralized Clinical Trials

    May 24, 2022, 09:26 AM by
    MMS Holdings Inc. (MMS) – a data-focused contract research organization (CRO) – announced a collaboration with THREAD® as its partner of choice for its decentralized clinical trial platform (DCT) and DCT-enabled services, solidifying MMS as a full-service DCT provider. The THREAD partnership is one initiative of many at MMS dedicated to accelerating a path toward adopting more patient-focused clinical trials
    Full story
  • New study highlights talent needed to grow the biosimilars sector

    May 24, 2022, 09:26 AM by
    The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity® Reports: Biosimilars 2022. The new report features interviews with leaders of biosimilars companies who give their unique insights into the challenges and opportunities facing this fast-growing sector and the leadership needed to grow the industry, including the power of creating strong in-house knowledge and evaluating where this talent already exists.
    Full story
  • Creative Proteomics Cytokine Unveils Tumor Necrosis Factors (TNF) Detection Service

    May 24, 2022, 09:26 AM by
    Full story
  • Creative Proteomics Lipidomics Platform Boosts Short Chain Fatty Acids Research

    May 24, 2022, 09:26 AM by
    Full story
  • «
  • 131
  • 132
  • 133
  • 134 (current)
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy